Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genfit Addresses Multiple Transition Issues With CEO Change

Sep 04 2019

• By Joseph Haas

Transition Vision Strategy Execution Speedometer Plan 3d Illustration - Illustration — Pascal Prigent will position Genfit for the commercial stage • Source: Shutterstock

Related Content

Genfit Assesses Optimal Elafibranor NASH Combo Therapy Opportunity

Jun 24 2019

Genfit Hopes To Make Case For First-Line Treatment In NASH

Apr 04 2019

Intercept Retakes The Lead In NASH

Feb 19 2019

Finance Watch: Genfit Launches IPO To Expand US Presence Ahead Of Phase III NASH Results

Mar 28 2019

Related Companies

Genfit SA

GSK plc

Eli Lilly and Company

Intercept Pharmaceuticals, Inc.

Additional Topics

Leadership Business Strategies Companies Commercial Liver & Hepatic BioPharmaceutical

More from Leadership

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window